These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24376205)

  • 1. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies.
    Bhardwaj A; Kaur J; Wuest F; Knaus EE
    ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid fluorescent conjugates of COX-2 inhibitors: search for a COX-2 isozyme imaging cancer biomarker.
    Bhardwaj A; Kaur J; Sharma SK; Huang Z; Wuest F; Knaus EE
    Bioorg Med Chem Lett; 2013 Jan; 23(1):163-8. PubMed ID: 23200247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Evaluation of an (18)F-Labeled Radiotracer Based on Celecoxib-NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase-2 (COX-2).
    Kaur J; Tietz O; Bhardwaj A; Marshall A; Way J; Wuest M; Wuest F
    ChemMedChem; 2015 Oct; 10(10):1635-40. PubMed ID: 26287271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New celecoxib derivatives as anti-inflammatory agents.
    Szabó G; Fischer J; Kis-Varga A; Gyires K
    J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of celecoxib and rofecoxib for the membrane permeabilizing activity.
    Yamakawa N; Suzuki K; Yamashita Y; Katsu T; Hanaya K; Shoji M; Sugai T; Mizushima T
    Bioorg Med Chem; 2014 Apr; 22(8):2529-34. PubMed ID: 24650702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
    Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors.
    Abdur Rahim M; Praveen Rao PN; Bhardwaj A; Kaur J; Huang Z; Knaus EE
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6074-80. PubMed ID: 21890358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
    Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
    Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents.
    Abdel-Aziz HA; Al-Rashood KA; ElTahir KE; Suddek GM
    Eur J Med Chem; 2014 Jun; 80():416-22. PubMed ID: 24794773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
    Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
    Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and bioactivities of Celecoxib analogues or derivatives.
    Zhou S; Yang S; Huang G
    Bioorg Med Chem; 2017 Sep; 25(17):4887-4893. PubMed ID: 28757100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hit identification and biological evaluation of anticancer pyrazolopyrimidines endowed with anti-inflammatory activity.
    Alcaro S; Artese A; Botta M; Zizzari AT; Orallo F; Ortuso F; Schenone S; Brullo C; Yáñez M
    ChemMedChem; 2010 Aug; 5(8):1242-6. PubMed ID: 20564576
    [No Abstract]   [Full Text] [Related]  

  • 13. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
    Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
    Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
    Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
    Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
    Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
    J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors.
    Chandna N; Kumar S; Kaushik P; Kaushik D; Roy SK; Gupta GK; Jachak SM; Kapoor JK; Sharma PK
    Bioorg Med Chem; 2013 Aug; 21(15):4581-90. PubMed ID: 23769654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
    Grover J; Kumar V; Sobhia ME; Jachak SM
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation.
    Tietz O; Kaur J; Bhardwaj A; Wuest FR
    Org Biomol Chem; 2016 Jul; 14(30):7250-7. PubMed ID: 27383140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
    Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
    Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.